Hopes for a separate board responsible for certifying cardiologists were dashed Friday when leaders laying the groundwork for ...

For all news and slides from the THT 2025 meeting, check out our conference page and or tune in to the Heart Sounds podcast ...

The polygenic risk score appears to identify patients who may benefit most from LDL-lowering therapy, say researchers.

Guidance around complete revascularization and intracoronary imaging is strengthened, and Impella gets a recommendation.

A study comparing GLP-1 users to others on antidiabetic drugs showed no added risk once confounders were accounted for.

There’s no scientific evidence to support anecdotal claims—on social media or elsewhere—of a bump, Jonathan Drezner says.

The polygenic risk score appears to identify patients who may benefit most from LDL-lowering therapy, say researchers.

Clyde Yancy, Suzanne Baron, and Bruce Rutkin discuss ways to address the undertreatment of CVD in women at the patient, provider, structural, and societal levels.

Clyde Yancy talks to Sharonne Hayes and Robert Harrington about the barriers that have historically hindered diagnosing heart ...

A patient who, despite risk factors or comorbidities, can get on a treadmill faces low mortality risk. But the reverse is ...

The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.

This month: smelling skills predict stroke risk, insights from LGBTQ+ clinicians, BP screening in public spaces, and more.